- First-quarter revenues totaled $18.32 billion, compared to $17.34 billion in the same period last year
- Net income attributable to the company was $1.61 billion or $6.45 per share in Q1, vs. $1.59 billion or $5.93 per share a year earlier
- Adjusted EBITDA increased to $3.73 billion in the March quarter from $3.53 billion in Q1 2024
- The company ended the quarter with operating cash flows of $1.65 billion, vs. $2.47 billion in the prior-year quarter
- Same-facility admissions increased 2.6% year-over-year, and same-facility equivalent admissions rose by 2.8% in Q1
- During the first quarter, HCA repurchased 7.76 million shares of its common stock for $2.5 billion
- The board declared a quarterly cash dividend of $0.72 per share, to be paid on June 30 to stockholders of record at the close of business on June 16, 2025
- The management continues to expect FY25 revenues to be in the range of $72.80 billion to $75.80 billion
Market News
Earnings Summary: HCA Healthcare reports higher Q1 2025 revenue and profit
HCA Healthcare, Inc. (NYSE: HCA) on Friday reported an increase in revenues and net income for the first quarter of 2025. The hospital chain also reaffirmed its full-year 2025 guidance. First-quarter revenues totaled $18.32 billion, compared to $17.34 billion in the same period last year Net income attributable to the company was $1.61 billion or […]
“HCA Healthcare, Inc. (NYSE: HCA) on Friday reported an increase in revenues and net income for the first quarter of 2025. The hospital chain also reaffirmed its full-year 2025 guidance. First-quarter revenues totaled $18.32 billion, compared to $17.34 billion in the same period last year Net income attributable to the company was $1.61 billion or […]
· April 25, 2025
HCA Healthcare, Inc. (NYSE: HCA) on Friday reported an increase in revenues and net income for the first quarter of 2025. The hospital chain also reaffirmed its full-year 2025 guidance.
ADVERTISEMENT